Advances in the development of biomarkers for epilepsy

The Lancet Neurology

Volumn 15, Issue 8, 2016, Pages 843-856

  Pitkänen, Asla ^a   Löscher, Wolfgang ^b,c   Vezzani, Annamaria ^d   Becker, Albert J ^e   Simonato, Michele ^g,h   Lukasiuk, Katarzyna ⁱ   Gröhn, Olli ^a   Bankstahl, Jens P ^j   Friedman, Alon ^k,l   Aronica, Eleonora ^m,n,o   Gorter, Jan A ⁿ   Ravizza, Teresa ^d   Sisodiya, Sanjay M ^p,q   Kokaia, Merab ^r   Beck, Heinz ^f,s  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b UNIVERSITY OF VETERINARY MEDICINE HANNOVER   (Germany)

^c CENTER FOR SYSTEMS NEUROSCIENCE   (Germany)

^d MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^e UNIVERSITY HOSPITAL BONN   (Germany)

^f UNIVERSITY OF BONN   (Germany)

^g UNIVERSITY OF FERRARA   (Italy)

^h VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

ⁱ NENCKI INSTITUTE OF EXPERIMENTAL BIOLOGY   (Poland)

^j HANNOVER MEDICAL SCHOOL   (Germany)

^k BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^l DALHOUSIE UNIVERSITY   (Canada)

^m UNIVERSITY OF AMSTERDAM   (Netherlands)

ⁿ UNIVERSITY OF AMSTERDAM   (Netherlands)

^o STICHTING EPILEPSIE INSTELLINGEN NEDERLAND SEIN   (Netherlands)

^p UNIVERSITY COLLEGE LONDON   (United Kingdom)

^q EPILEPSY SOCIETY   (United Kingdom)

^r LUND UNIVERSITY HOSPITAL   (Sweden)

^s GERMAN CENTER FOR NEURODEGENERATIVE DISEASES DZNE   (Germany)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; MICRORNA;

CLINICAL FEATURE; COMORBIDITY; EPILEPSY; HIGH FREQUENCY OSCILLATION; HUMAN; MOLECULAR IMAGING; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; PROPHYLAXIS; REMISSION; REVIEW; SEIZURE SUSCEPTIBILITY; ANIMAL; DIAGNOSTIC IMAGING; DIFFUSION WEIGHTED IMAGING; ELECTROENCEPHALOGRAPHY; GENETICS; METABOLISM;

ANIMALS; BIOMARKERS; DIFFUSION MAGNETIC RESONANCE IMAGING; ELECTROENCEPHALOGRAPHY; EPILEPSY; HUMANS; MICRORNAS;

EID: 84973334395     PISSN: 14744422     EISSN: 14744465     Source Type: Journal    
DOI: 10.1016/S1474-4422(16)00112-5     Document Type: Review

References (133)

1. Epilepsy fact sheet WHO, (accessed Oct 15, 2015). http://www.who.int/mediacentre/factsheets/fs999/en/.
2. Perucca E, French J, Bialer M Development of new antiepileptic drugs: challenges, incentives, and recent advances. Lancet Neurol 2007, 6:793-804.
3. Pitkänen A, Immonen R Epilepsy related to traumatic brain injury. Neurotherapeutics 2014, 11:286-296.
4. Pitkänen A, Engel J Past and present definitions of epileptogenesis and its biomarkers. Neurotherapeutics 2014, 11:231-241.
5. Nieh SE, Sherr EH Epileptic encephalopathies: new genes and new pathways. Neurotherapeutics 2014, 11:796-806.
6. Schmidt D, Sillanpaa M Evidence-based review on the natural history of the epilepsies. Curr Opin Neurol 2012, 25:159-163.
7. Gaitatzis A, Trimble MR, Sander JW The psychiatric comorbidity of epilepsy. Acta Neurol Scand 2004, 110:207-220.
8. Gaitatzis A, Carroll K, Majeed A, Sander W The epidemiology of the comorbidity of epilepsy in the general population. Epilepsia 2004, 45:1613-1622.
9. Kandratavicius L, Lopes-Aguiar C, Bueno-Junior LS, Romcy-Pereira RN, Hallak JE, Leite JP Psychiatric comorbidities in temporal lobe epilepsy: possible relationships between psychotic disorders and involvement of limbic circuits. Rev Bras Psiquiatr 2012, 34:454-466.
10. Simonato M, Brooks-Kayal AR, Engel J, et al. The challenge and promise of anti-epileptic therapy development in animal models. Lancet Neurol 2014, 13:949-960.
11. Wang J, Yu JT, Tan L, et al. Genome-wide circulating microRNA expression profiling indicates biomarkers for epilepsy. Sci Rep 2015, 5:9522.
12. Wang J, Tan L, Tan L, et al. Circulating microRNAs are promising novel biomarkers for drug-resistant epilepsy. Sci Rep 2015, 5:10201.
13. Choy M, Dube CM, Patterson K, et al. A novel, noninvasive, predictive epilepsy biomarker with clinical potential. J Neurosci 2014, 34:8672-8684.
14. Pollard JR, Eidelman O, Mueller GP, et al. The TARC/sICAM5 ratio in patient plasma is a candidate biomarker for drug resistant epilepsy. Front Neurol 2012, 3:181.
15. Bragin A, Engel J, Wilson CL, Fried I, Mathern GW Hippocampal and entorhinal cortex high-frequency oscillations (100-500 Hz) in human epileptic brain and in kainic acid-treated rats with chronic seizures. Epilepsia 1999, 40:127-137.
16. Andrade-Valenca LP, Dubeau F, Mari F, Zelmann R, Gotman J Interictal scalp fast oscillations as a marker of the seizure onset zone. Neurology 2011, 77:524-531.
17. Labate A, Cherubini A, Tripepi G, et al. White matter abnormalities differentiate severe from benign temporal lobe epilepsy. Epilepsia 2015, 56:1109-1116.
18. Noebels J Pathway-driven discovery of epilepsy genes. Nat Neurosci 2015, 18:344-350.
19. Kauffman MA, Levy EM, Consalvo D, Mordoh J, Kochen S GABABR1 (G1465A) gene variation and temporal lobe epilepsy controversy: new evidence. Seizure 2008, 17:567-571.
20. Xi B, Chen J, Yang L, Wang W, Fu M, Wang C GABBR1 gene polymorphism(G1465A) is associated with temporal lobe epilepsy. Epilepsy Res 2011, 96:58-63.
21. Gambardella A, Manna I, Labate A, et al. GABA(B) receptor 1 polymorphism (G1465A) is associated with temporal lobe epilepsy. Neurology 2003, 60:560-563.
22. Wang X, Sun W, Zhu X, et al. Association between the gamma-aminobutyric acid type B receptor 1 and 2 gene polymorphisms and mesial temporal lobe epilepsy in a Han Chinese population. Epilepsy Res 2008, 81:198-203.
23. Pernhorst K, Raabe A, Niehusmann P, et al. Promoter variants determine gamma-aminobutyric acid homeostasis-related gene transcription in human epileptic hippocampi. J Neuropathol Exp Neurol 2011, 70:1080-1088.
24. Haerian BS, Baum L, Kwan P, et al. Contribution of GABRG2 polymorphisms to risk of epilepsy and febrile seizure: a multicenter cohort study and meta-analysis. Mol Neurobiol 2015, published online Oct 9. 10.1007/s12035-015-9457-y.
25. Balan S, Sathyan S, Radha SK, Joseph V, Radhakrishnan K, Banerjee M GABRG2, rs211037 is associated with epilepsy susceptibility, but not with antiepileptic drug resistance and febrile seizures. Pharmacogenet Genomics 2013, 23:605-610.
26. Darrah SD, Miller MA, Ren D, et al. Genetic variability in glutamic acid decarboxylase genes: associations with post-traumatic seizures after severe TBI. Epilepsy Res 2013, 103:180-194.
27. Stefulj J, Bordukalo-Niksic T, Hecimovic H, Demarin V, Jernej B Epilepsy and serotonin (5HT): variations of 5HT-related genes in temporal lobe epilepsy. Neurosci Lett 2010, 478:29-31.
28. Manna I, Labate A, Gambardella A, et al. Serotonin transporter gene (5-Htt): association analysis with temporal lobe epilepsy. Neurosci Lett 2007, 421:52-56.
29. Li J, Lin H, Zhu X, et al. Association study of functional polymorphisms in serotonin transporter gene with temporal lobe epilepsy in Han Chinese population. Eur J Neurol 2012, 19:351-353.
30. Genetic determinants of common epilepsies: a meta-analysis of genome-wide association studies. Lancet Neurol 2014, 13:893-903. International League Against Epilepsy Consortium on Complex Epilepsies.
31. Stogmann E, Zimprich A, Baumgartner C, Aull-Watschinger S, Hollt V, Zimprich F A functional polymorphism in the prodynorphin gene promotor is associated with temporal lobe epilepsy. Ann Neurol 2002, 51:260-263.
32. Scher AI, Wu H, Tsao JW, et al. MTHFR C677T genotype as a risk factor for epilepsy including post-traumatic epilepsy in a representative military cohort. J Neurotrauma 2011, 28:1739-1745.
33. Lv RJ, He JS, Fu YH, et al. ASIC1a polymorphism is associated with temporal lobe epilepsy. Epilepsy Res 2011, 96:74-80.
34. Zhang B, Chen M, Yang H, Wu T, Song C, Guo R Evidence for involvement of the CD40/CD40L system in post-stroke epilepsy. Neurosci Lett 2014, 567:6-10.
35. Kanemoto K, Kawasaki J, Yuasa S, et al. Increased frequency of interleukin-1beta-511T allele in patients with temporal lobe epilepsy, hippocampal sclerosis, and prolonged febrile convulsion. Epilepsia 2003, 44:796-799.
36. Kanemoto K, Kawasaki J, Miyamoto T, Obayashi H, Nishimura M Interleukin (IL)1beta, IL-1alpha, and IL-1 receptor antagonist gene polymorphisms in patients with temporal lobe epilepsy. Ann Neurol 2000, 47:571-574.
37. Salzmann A, Perroud N, Crespel A, Lambercy C, Malafosse A Candidate genes for temporal lobe epilepsy: a replication study. Neurol Sci 2008, 29:397-403.
38. Yang H, Song Z, Yang GP, et al. The ALDH2 rs671 polymorphism affects post-stroke epilepsy susceptibility and plasma 4-HNE levels. PLoS One 2014, 9:e109634.
39. Liu Z, Yin X, Liu L, et al. Association of KEAP1 and NFE2L2 polymorphisms with temporal lobe epilepsy and drug resistant epilepsy. Gene 2015, 571:231-236.
40. Labate A, Manna I, Gambardella A, et al. Association between the M129V variant allele of PRNP gene and mild temporal lobe epilepsy in women. Neurosci Lett 2007, 421:1-4.
41. Nwaobi SE, Cuddapah VA, Patterson KC, Randolph AC, Olsen ML The role of glial-specific Kir4.1 in normal and pathological states of the CNS. Acta Neuropathol 2016, published online March 9. 10.1007/s00401-016-1553-1.
42. Buono RJ, Lohoff FW, Sander T, et al. Association between variation in the human KCNJ10 potassium ion channel gene and seizure susceptibility. Epilepsy Res 2004, 58:175-183.
43. Heuser K, Nagelhus EA, Tauboll E, et al. Variants of the genes encoding AQP4 and Kir4.1 are associated with subgroups of patients with temporal lobe epilepsy. Epilepsy Res 2010, 88:55-64.
44. Lv RJ, He JS, Fu YH, et al. A polymorphism in CALHM1 is associated with temporal lobe epilepsy. Epilepsy Behav 2011, 20:681-685.
45. Zhu WY, Jiang P, He X, et al. Contribution of NRG1 gene polymorphisms in temporal lobe epilepsy. J Child Neurol 2016, 31:271-276.
46. Shen N, Zhu X, Lin H, et al. Role of BDNF Val66Met functional polymorphism in temporal lobe epilepsy. Int J Neurosci 2016, 126:436-441.
47. Jamali S, Salzmann A, Perroud N, et al. Functional variant in complement C3 gene promoter and genetic susceptibility to temporal lobe epilepsy and febrile seizures. PLoS One 2010, 5:e12740.
48. Leu C, Coppola A, Sisodiya SM Progress from genome-wide association studies and copy number variant studies in epilepsy. Curr Opin Neurol 2016, 29:158-167.
49. Bartel DP MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004, 116:281-297.
50. Jimenez-Mateos EM, Henshall DC Epilepsy and microRNA. Neuroscience 2013, 238:218-229.
51. Aronica E, Fluiter K, Iyer A, et al. Expression pattern of miR-146a, an inflammation-associated microRNA, in experimental and human temporal lobe epilepsy. Eur J Neurosci 2010, 31:1100-1107.
52. Kaalund SS, Veno MT, Bak M, et al. Aberrant expression of miR-218 and miR-204 in human mesial temporal lobe epilepsy and hippocampal sclerosis-convergence on axonal guidance. Epilepsia 2014, 55:2017-2027.
53. Miller-Delaney SF, Bryan K, Das S, et al. Differential DNA methylation profiles of coding and non-coding genes define hippocampal sclerosis in human temporal lobe epilepsy. Brain 2015, 138:616-631.
54. Zucchini S, Marucci G, Paradiso B, et al. Identification of miRNAs differentially expressed in human epilepsy with or without granule cell pathology. PLoS One 2014, 9:e105521.
55. Alvarez-Erviti L, Seow Y, Yin H, Betts C, Lakhal S, Wood MJ Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes. Nat Biotechnol 2011, 29:341-345.
56. Haqqani AS, Delaney CE, Tremblay TL, Sodja C, Sandhu JK, Stanimirovic DB Method for isolation and molecular characterization of extracellular microvesicles released from brain endothelial cells. Fluids Barriers CNS 2013, 10:4.
57. Jin XF, Wu N, Wang L, Li J Circulating microRNAs: a novel class of potential biomarkers for diagnosing and prognosing central nervous system diseases. Cell Mol Neurobiol 2013, 33:601-613.
58. Gorter JA, Iyer A, White I, et al. Hippocampal subregion-specific microRNA expression during epileptogenesis in experimental temporal lobe epilepsy. Neurobiol Dis 2014, 62:508-520.
59. Roncon P, Soukupova M, Binaschi A, et al. MicroRNA profiles in hippocampal granule cells and plasma of rats with pilocarpine-induced epilepsy-comparison with human epileptic samples. Sci Rep 2015, 5:14143.
60. McDonald JS, Milosevic D, Reddi HV, Grebe SK, Algeciras-Schimnich A Analysis of circulating microRNA: preanalytical and analytical challenges. Clin Chem 2011, 57:833-840.
61. Immonen R, Kharatishvili I, Gröhn O, Pitkänen A MRI biomarkers for post-traumatic epileptogenesis. J Neurotrauma 2013, 30:1305-1309.
62. Lewis DV, Shinnar S, Hesdorffer DC, et al. Hippocampal sclerosis after febrile status epilepticus: the FEBSTAT study. Ann Neurol 2014, 75:178-185.
63. Lehto LJ, Sierra A, Corum CA, et al. Detection of calcifications in vivo and ex vivo after brain injury in rat using SWIFT. Neuroimage 2012, 61:761-772.
64. Fisher RS, van Emde BW, Blume W, et al. Epileptic seizures and epilepsy: definitions proposed by the International League Against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE). Epilepsia 2005, 46:470-472.
65. Fisher RS, Acevedo C, Arzimanoglou A, et al. ILAE official report: a practical clinical definition of epilepsy. Epilepsia 2014, 55:475-482.
66. Jacobs J, Staba R, Asano E, et al. High-frequency oscillations (HFOs) in clinical epilepsy. Prog Neurobiol 2012, 98:302-315.
67. Bragin A, Wilson CL, Almajano J, Mody I, Engel J High-frequency oscillations after status epilepticus: epileptogenesis and seizure genesis. Epilepsia 2004, 45:1017-1023.
68. Haegelen C, Perucca P, Chatillon CE, et al. High-frequency oscillations, extent of surgical resection, and surgical outcome in drug-resistant focal epilepsy. Epilepsia 2013, 54:848-857.
69. Weiss SA, Banks GP, McKhann GM, et al. Ictal high frequency oscillations distinguish two types of seizure territories in humans. Brain 2013, 136:3796-3808.
70. Akiyama T, McCoy B, Go CY, et al. Focal resection of fast ripples on extraoperative intracranial EEG improves seizure outcome in pediatric epilepsy. Epilepsia 2011, 52:1802-1811.
71. Kerber K, Dumpelmann M, Schelter B, et al. Differentiation of specific ripple patterns helps to identify epileptogenic areas for surgical procedures. Clin Neurophysiol 2014, 125:1339-1345.
72. Salami P, Levesque M, Benini R, Behr C, Gotman J, Avoli M Dynamics of interictal spikes and highfrequency oscillations during epileptogenesis in temporal lobe epilepsy. Neurobiol Dis 2014, 67:97-106.
73. Levesque M, Salami P, Gotman J, Avoli M Two seizure-onset types reveal specific patterns of high-frequency oscillations in a model of temporal lobe epilepsy. J Neurosci 2012, 32:13264-13272.
74. Jacobs J, Vogt C, LeVan P, Zelmann R, Gotman J, Kobayashi K The identification of distinct high-frequency oscillations during spikes delineates the seizure onset zone better than high-frequency spectral power changes. Clin Neurophysiol 2016, 127:129-142.
75. Xiang J, Tenney JR, Korman AM, et al. Quantification of interictal neuromagnetic activity in absence epilepsy with accumulated source imaging. Brain Topogr 2015, 28:904-914.
76. Tenney JR, Fujiwara H, Horn PS, et al. Low- and high-frequency oscillations reveal distinct absence seizure networks. Ann Neurol 2014, 76:558-567.
77. Xiang J, Luo Q, Kotecha R, et al. Accumulated source imaging of brain activity with both low and high-frequency neuromagnetic signals. Front Neuroinform 2014, 8:57.
78. Amiri M, Lina JM, Pizzo F, Gotman J High frequency oscillations and spikes: separating real HFOs from false oscillations. Clin Neurophysiol 2016, 127:187-196.
79. Dümpelmann M, Jacobs J, Schulze-Bonhage A Temporal and spatial characteristics of high frequency oscillations as a new biomarker in epilepsy. Epilepsia 2015, 56:197-206.
80. Kharatishvili I, Pitkänen A Posttraumatic epilepsy. Curr Opin Neurol 2010, 23:183-188.
81. Rattka M, Brandt C, Bankstahl M, Bröer S, Löscher W Enhanced susceptibility to the GABA antagonist pentylenetetrazole during the latent period following a pilocarpine-induced status epilepticus in rats. Neuropharmacology 2011, 60:505-512.
82. Bolkvadze T, Pitkänen A Development of post-traumatic epilepsy after controlled cortical impact and lateral fluid-percussion-induced brain injury in the mouse. J Neurotrauma 2012, 29:789-812.
83. Rattka M, Brandt C, Löscher W Do proconvulsants modify or halt epileptogenesis? Pentylenetetrazole is ineffective in two rat models of temporal lobe epilepsy. Eur J Neurosci 2012, 36:2505-2520.
84. Brima T, Otahal J, Mares P Increased susceptibility to pentetrazol-induced seizures in developing rats after cortical photothrombotic ischemic stroke at P7. Brain Res 2013, 1507:146-153.
85. Mishra AM, Bai X, Sanganahalli BG, et al. Decreased resting functional connectivity after traumatic brain injury in the rat. PLoS One 2014, 9:e95280.
86. Brandt C, Tollner K, Klee R, Bröer S, Löscher W Effective termination of status epilepticus by rational polypharmacy in the lithium-pilocarpine model in rats: window of opportunity to prevent epilepsy and prediction of epilepsy by biomarkers. Neurobiol Dis 2015, 75:78-90.
87. Bröer S, Löscher W Novel combinations of phenotypic biomarkers predict development of epilepsy in the lithium-pilocarpine model of temporal lobe epilepsy in rats. Epilepsy Behav 2015, 53:98-107.
88. 1H-magnetic resonance spectroscopy to detect putative biomarkers of tissue epileptogenicity. Epilepsia 2012, 53:1907-1916.
89. Wieser HG, Bancaud J, Talairach J, Bonis A, Szikla G Comparative value of spontaneous and chemically and electrically induced seizures in establishing the lateralization of temporal lobe seizures. Epilepsia 1979, 20:47-59.
90. Barba C, Barbati G, Di Giuda D, et al. Diagnostic yield and predictive value of provoked ictal SPECT in drug-resistant epilepsies. J Neurol 2012, 259:1613-1622.
91. Barba C, Di GD, Fuggetta F, Colicchio G Provoked ictal SPECT in temporal and extratemporal drug-resistant epileptic patients: comparison of statistical parametric mapping and qualitative analysis. Epilepsy Res 2009, 84:6-14.
92. So N, Gloor P, Quesney LF, Jones-Gotman M, Olivier A, Andermann F Depth electrode investigations in patients with bitemporal epileptiform abnormalities. Ann Neurol 1989, 25:423-431.
93. 18F-fluorodeoxyglucose-small animal positron emission tomography study. Neuroscience 2009, 162:972-979.
94. Shultz SR, Cardamone L, Liu YR, et al. Can structural or functional changes following traumatic brain injury in the rat predict epileptic outcome?. Epilepsia 2013, 54:1240-1250.
95. McGinnity CJ, Koepp MJ, Hammers A, et al. NMDA receptor binding in focal epilepsies. J Neurol Neurosurg Psychiatry 2015, 86:1150-1157.
96. 11C-flumazenil and PET. J Nucl Med 2012, 53:1974-1983.
97. Filiou MD, Arefin AS, Moscato P, Graeber MB 'Neuroinflammation' differs categorically from inflammation: transcriptomes of Alzheimer's disease, Parkinson's disease, schizophrenia and inflammatory diseases compared. Neurogenetics 2014, 15:201-212.
98. Vezzani A, Maroso M, Balosso S, Sanchez MA, Bartfai T IL-1 receptor/Toll-like receptor signaling in infection, inflammation, stress and neurodegeneration couples hyperexcitability and seizures. Brain Behav Immun 2011, 25:1281-1289.
99. Vezzani A, French J, Bartfai T, Baram TZ The role of inflammation in epilepsy. Nat Rev Neurol 2011, 7:31-40.
100. Vezzani A, Aronica E, Mazarati A, Pittman QJ Epilepsy and brain inflammation. Exp Neurol 2013, 244:11-21.
101. Ravizza T, Balosso S, Vezzani A Inflammation and prevention of epileptogenesis. Neurosci Lett 2011, 497:223-230.
102. Vezzani A, Fujinami RS, White HS, et al. Infections, inflammation and epilepsy. Acta Neuropathol 2016, 131:211-234.
103. Tomkins O, Feintuch A, Benifla M, Cohen A, Friedman A, Shelef I Blood-brain barrier breakdown following traumatic brain injury: a possible role in posttraumatic epilepsy. Cardiovasc Psychiatry Neurol 2011, 2011:765923.
104. Pulli B, Chen JW Imaging neuroinflammation-from bench to bedside. J Clin Cell Immunol 2014, 5:226.
105. Amhaoul H, Staelens S, Dedeurwaerdere S Imaging brain inflammation in epilepsy. Neuroscience 2014, 279:238-252.
106. Barry JM, Choy M, Dube C, et al. T2 relaxation time post febrile status epilepticus predicts cognitive outcome. Exp Neurol 2015, 269:242-252.
107. Gershen LD, Zanotti-Fregonara P, Dustin IH, et al. Neuroinflammation in temporal lobe epilepsy measured using positron emission tomographic imaging of translocator protein. JAMA Neurol 2015, 72:882-888.
108. Shinnar S, Hesdorffer DC, Nordli DR, et al. Phenomenology of prolonged febrile seizures: results of the FEBSTAT study. Neurology 2008, 71:170-176.
109. Cacheaux LP, Ivens S, David Y, et al. Transcriptome profiling reveals TGF-beta signaling involvement in epileptogenesis. J Neurosci 2009, 29:8927-8935.
110. Weissberg I, Wood L, Kamintsky L, et al. Albumin induces excitatory synaptogenesis through astrocytic TGF-beta/ALK5 signaling in a model of acquired epilepsy following blood-brain barrier dysfunction. Neurobiol Dis 2015, 78:115-125.
111. Shlosberg D, Benifla M, Kaufer D, Friedman A Blood-brain barrier breakdown as a therapeutic target in traumatic brain injury. Nat Rev Neurol 2010, 6:393-403.
112. Pitkänen A, Roivainen R, Lukasiuk K Development of epilepsy after ischaemic stroke. Lancet Neurol 2016, 15:185-197.
113. Rodriguez-Baeza A, Reina-de la TF, Poca A, Marti M, Garnacho A Morphological features in human cortical brain microvessels after head injury: a three-dimensional and immunocytochemical study. Anat Rec A Discov Mol Cell Evol Biol 2003, 273:583-593.
114. Rigau V, Morin M, Rousset MC, et al. Angiogenesis is associated with blood-brain barrier permeability in temporal lobe epilepsy. Brain 2007, 130:1942-1956.
115. van Vliet EA, da Costa Araújo S, Redeker S, van Schaik R, Aronica E, Gorter JA Blood-brain barrier leakage may lead to progression of temporal lobe epilepsy. Brain 2007, 130:521-534.
116. Raabe A, Schmitz AK, Pernhorst K, et al. Cliniconeuropathologic correlations show astroglial albumin storage as a common factor in epileptogenic vascular lesions. Epilepsia 2012, 53:539-548.
117. Wei EP, Hamm RJ, Baranova AI, Povlishock JT The long-term microvascular and behavioural consequences of experimental traumatic brain injury after hypothermic intervention. J Neurotrauma 2009, 26:527-537.
118. Ding G, Jiang Q, Li L, et al. Detection of BBB disruption and hemorrhage by Gd-DTPA enhanced MRI after embolic stroke in rat. Brain Res 2006, 1114:195-203.
119. Veksler R, Shelef I, Friedman A Blood-brain barrier imaging in human neuropathologies. Arch Med Res 2014, 45:646-652.
120. Tomkins O, Shelef I, Kaizerman I, et al. Blood-brain barrier disruption in post-traumatic epilepsy. J Neurol Neurosurg Psychiatry 2008, 79:774-777.
121. Pavlovsky L, Seiffert E, Heinemann U, Korn A, Golan H, Friedman A Persistent BBB disruption may underlie alpha interferon-induced seizures. J Neurol 2005, 252:42-46.
122. Pitkänen A, Kharatishvili I, Narkilahti S, Lukasiuk K, Nissinen J Administration of diazepam during status epilepticus reduces development and severity of epilepsy in rat. Epilepsy Res 2005, 63:27-42.
123. Shrot S, Ramaty E, Biala Y, et al. Prevention of organophosphate-induced chronic epilepsy by early benzodiazepine treatment. Toxicology 2014, 323:19-25.
124. Ravizza T, Gagliardi B, Noe F, Boer K, Aronica E, Vezzani A Innate and adaptive immunity during epileptogenesis and spontaneous seizures: evidence from experimental models and human temporal lobe epilepsy. Neurobiol Dis 2008, 29:142-160.
125. Dyhrfjeld-Johnsen J, Berdichevsky Y, Swiercz W, Sabolek H, Staley KJ Interictal spikes precede ictal discharges in an organotypic hippocampal slice culture model of epileptogenesis. J Clin Neurophysiol 2010, 27:418-424.
126. Erdmann J All aboard: will molecular tumor boards help cancer patients?. Nat Med 2015, 21:655-656.
127. McDermott JE, Wang J, Mitchell H, et al. Challenges in biomarker discovery: combining expert insights with statistical analysis of complex omics data. Expert Opin Med Diagn 2013, 7:37-51.
128. Atluri G, Padmanabhan K, Fang G, et al. Complex biomarker discovery in neuroimaging data: finding a needle in a haystack. Neuroimage Clin 2013, 3:123-131.
129. Humpel C Identifying and validating biomarkers for Alzheimer's disease. Trends Biotechnol 2011, 29:26-32.
130. Rosen C, Hansson O, Blennow K, Zetterberg H Fluid biomarkers in Alzheimer's disease-current concepts. Mol Neurodegener 2013, 8:20.
131. Di Battista AP, Buonora JE, Rhind SG, et al. Blood biomarkers in moderate-to-severe traumatic brain injury: potential utility of a multi-marker approach in characterizing outcome. Front Neurol 2015, 6:110.
132. Milward EA, Moscato P, Riveros C, Johnstone DM Beyond statistics: a new combinatorial approach to identifying biomarker panels for the early detection and diagnosis of Alzheimer's disease. J Alzheimers Dis 2014, 39:211-217.
133. Gao Z, Roy A, Tan M Multistage adaptive biomarker-directed targeted design for randomized clinical trials. Contemp Clin Trials 2015, 42:119-131.